The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dikopoulos, N.
Right arrow Articles by Reimann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dikopoulos, N.
Right arrow Articles by Reimann, J.
The Journal of Immunology, 2005, 174: 99-109.
Copyright © 2005 by The American Association of Immunologists

Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells1

Nektarios Dikopoulos2,*, Antonio Bertoletti{dagger}, Andrea Kröger{ddagger}, Hansjörg Hauser{ddagger}, Reinhold Schirmbeck* and Jörg Reimann*

* Department of Medical Microbiology and Immunology, University of Ulm, Ulm, Germany; {dagger} Institute of Hepatology, University College of London, London, United Kingdom; and {ddagger} German Research Centre for Biotechnology, Braunschweig, Germany

Pleiotropic, immunomodulatory effects of type I IFN on T cell responses are emerging. We used vaccine-induced, antiviral CD8+ T cell responses in IFN-{beta} (IFN-{beta}–/–)- or type I IFN receptor (IFNAR–/–)-deficient mice to study immunomodulating effects of type I IFN that are not complicated by the interference of a concomitant virus infection. Compared with normal B6 mice, IFNAR–/– or IFN-{beta}–/– mice have normal numbers of CD4+ and CD8+ T cells, and CD25+FoxP3+ T regulatory (TR) cells in liver and spleen. Twice as many CD8+ T cells specific for different class I-restricted epitopes develop in IFNAR–/– or IFN-{beta}–/– mice than in normal animals after peptide- or DNA-based vaccination. IFN-{gamma} and TNF-{alpha} production and clonal expansion of specific CD8+ T cells from normal and knockout mice are similar. CD25+FoxP3+ TR cells down-modulate vaccine-primed CD8+ T cell responses in normal, IFNAR–/–, or IFN-{beta}–/– mice to a comparable extent. Low IFN-{alpha} or IFN-{beta} doses (500–103 U/mouse) down-modulate CD8+ T cells priming in vivo. IFNAR- and IFN-{beta}-deficient mice generate 2- to 3-fold lower numbers of IL-10-producing CD4+ T cells after polyclonal or specific stimulation in vitro or in vivo. CD8+ T cell responses are thus subjected to negative control by both CD25+FoxP3+ TR cells and CD4+IL-10+ TR1 cells, but only development of the latter TR cells depends on type I IFN.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. S. Liu, J. Leerberg, K. MacDonald, G. R. Leggatt, and I. H. Frazer
IFN-{gamma} Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host
J. Immunol., July 1, 2009; 183(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wahl, W. Muller, F. Leithauser, G. Adler, F. Oswald, J. Reimann, R. Schirmbeck, A. Seier, J. M. Weiss, B. Prochnow, et al.
IL-20 Receptor 2 Signaling Down-Regulates Antigen-Specific T Cell Responses
J. Immunol., January 15, 2009; 182(2): 802 - 810.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Wang, H. D. Edington, U. N.M. Rao, D. M. Jukic, A. Radfar, H. Wang, and J. M. Kirkwood
Effects of High-Dose IFN{alpha}2b on Regional Lymph Node Metastases of Human Melanoma: Modulation of STAT5, FOXP3, and IL-17
Clin. Cancer Res., December 15, 2008; 14(24): 8314 - 8320.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bochtler, A. Kroger, R. Schirmbeck, and J. Reimann
Type I IFN-Induced, NKT Cell-Mediated Negative Control of CD8 T Cell Priming by Dendritic Cells
J. Immunol., August 1, 2008; 181(3): 1633 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wahl, P. Bochtler, R. Schirmbeck, and J. Reimann
Type I IFN-Producing CD4 V{alpha}14i NKT Cells Facilitate Priming of IL-10-Producing CD8 T Cells by Hepatocytes
J. Immunol., February 15, 2007; 178(4): 2083 - 2093.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bochtler, C. Wahl, R. Schirmbeck, and J. Reimann
Functional Adaptive CD4 Foxp3 T Cells Develop in MHC Class II-Deficient Mice
J. Immunol., December 15, 2006; 177(12): 8307 - 8314.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Wang, Y. Liu, J. Wang, G. Ding, W. Zhang, G. Chen, M. Zhang, S. Zheng, and X. Cao
Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble TNF Receptor
J. Immunol., August 15, 2006; 177(4): 2175 - 2185.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Aichele, H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke, and S. Vucikuja
Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.
J. Immunol., April 15, 2006; 176(8): 4525 - 4529.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Gerlach, S. Schimmer, S. Weiss, U. Kalinke, and U. Dittmer
Effects of type I interferons on friend retrovirus infection.
J. Virol., April 1, 2006; 80(7): 3438 - 3444.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Kawamura, N. Kadowaki, T. Kitawaki, and T. Uchiyama
Virus-stimulated plasmacytoid dendritic cells induce CD4+ cytotoxic regulatory T cells
Blood, February 1, 2006; 107(3): 1031 - 1038.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. A. Kolumam, S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
J. Exp. Med., September 6, 2005; 202(5): 637 - 650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.